Company Filing History:
Years Active: 2025
Title: Shelonitda Rose: Innovator in Leukemia Treatment
Introduction
Shelonitda Rose is a notable inventor based in Branchburg, NJ (US). He has made significant contributions to the field of medicine, particularly in the treatment of leukemia and myelodysplastic syndrome. His innovative approach combines existing therapies to enhance patient outcomes.
Latest Patents
Shelonitda holds a patent for "Azacitidine in combination with venetoclax, gilteritinib, midostaurin or other compounds for treating leukemia or myelodysplastic syndrome." This patent outlines methods for using 5-azacytidine in conjunction with additional agents to treat diseases and disorders, including acute myeloid leukemia (AML). He has 1 patent to his name, showcasing his commitment to advancing medical treatments.
Career Highlights
Shelonitda is currently employed at Celgene Quanticel Research, Inc., where he continues to work on innovative solutions in cancer treatment. His role at the company allows him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include C L Beach and Diana R Dunshee. Their collective expertise fosters a collaborative environment that enhances the research and development of new therapies.
Conclusion
Shelonitda Rose is a dedicated inventor whose work in leukemia treatment exemplifies the impact of innovation in medicine. His contributions are paving the way for improved therapies and better patient care.